- Reported transaction lines
- 2
- Buy lines
- 0
- Sell lines
- 2
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-112
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Shah Gaurav CEO · ROCKET PHARMACEUTICALS, INC. | RCKT ROCKET PHARMACEUTICALS, INC. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 1051358 · SEC code covers open-market or private transactions · Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. · The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs. | 2026-11-18 | 2026-11-20 | ≈ $4,826.45 2,216 shares/units | SEC 4 |
| Shah Gaurav CEO · ROCKET PHARMACEUTICALS, INC. | RCKT ROCKET PHARMACEUTICALS, INC. | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 1053574 · SEC code covers open-market or private transactions · Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. · The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs. | 2026-11-13 | 2026-11-17 | ≈ $6,795.00 3,020 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.